Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diaphragmatic weakness related to radiotherapy: 2 cases and a review.
Davion JB, Duthoit L, Starzyńska-Kubicka A, Perez T, Bocquillon P, Defebvre L, Nguyen The Tich S, Lefebvre G, Tard C. Davion JB, et al. Rev Neurol (Paris). 2022 Oct;178(8):796-801. doi: 10.1016/j.neurol.2022.02.459. Epub 2022 Jun 9. Rev Neurol (Paris). 2022. PMID: 35690475
Electro-clinical presentation of hereditary transthyretin related amyloidosis when presenting as a polyneuropathy of unknown origin in northern France.
Davion JB, Bocquillon P, Cassim F, Frezel N, Lacour A, Dhaenens CM, Maurage CA, Gibier JB, Hachulla E, Nguyen The Tich S, Defebvre L, Merle PE, Tard C. Davion JB, et al. Rev Neurol (Paris). 2021 Nov;177(9):1160-1167. doi: 10.1016/j.neurol.2021.02.392. Epub 2021 Jul 10. Rev Neurol (Paris). 2021. PMID: 34253345
RFC1: Motifs and phenotypes.
Delforge V, Tard C, Davion JB, Dujardin K, Wissocq A, Dhaenens CM, Mutez E, Huin V. Delforge V, et al. Among authors: davion jb. Rev Neurol (Paris). 2024 May;180(5):393-409. doi: 10.1016/j.neurol.2024.03.006. Epub 2024 Apr 15. Rev Neurol (Paris). 2024. PMID: 38627134 Free article. Review.
Real-life effectiveness 1 year after switching to avalglucosidase alfa in late-onset Pompe disease patients worsening on alglucosidase alfa therapy: A French cohort study.
Tard C, Bouhour F, Michaud M, Beltran S, Fournier M, Demurger F, Lagrange E, Nollet S, Sacconi S, Noury JB, Magot A, Cintas P, Renard D, Deibener-Kaminsky J, Lefeuvre C, Davion JB, Salort-Campana E, Arrassi A, Taouagh N, Spinazzi M; Pompe Study Group; Attarian S, Laforêt P. Tard C, et al. Among authors: davion jb. Eur J Neurol. 2024 Apr 8:e16292. doi: 10.1111/ene.16292. Online ahead of print. Eur J Neurol. 2024. PMID: 38587143
Effect of nusinersen after 3 years of treatment in 57 young children with SMA in terms of SMN2 copy number or type.
Audic F, Dubois SM, Durigneux J, Barnerias C, Isapof A, Nougues MC, Davion JB, Richelme C, Vuillerot C, Legoff L, Sabouraud P, Cances C, Laugel V, Ropars J, Espil-Taris C, Trommsdorff V, Pervillé A, Garcia-de-la-Banda MG, Testard H, Chouchane M, Walther-Louvier U, Schweizer C, Halbert C, Badri M, Quijano-Roy S, Chabrol B, Desguerre I. Audic F, et al. Among authors: davion jb. Arch Pediatr. 2024 Feb;31(2):117-123. doi: 10.1016/j.arcped.2023.10.009. Epub 2023 Dec 21. Arch Pediatr. 2024. PMID: 38135619
32 results